Timothy S. Nelson, President and CEO at MAP Pharmaceuticals, Inc. (MAPP), sold 30,000 shares at $14.47 ($434K) on 2010-03-01, disclosed to the SEC on 2010-03-03.
Scheduled sale ($434k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MAPP | SELL | 2011-12-22 | $290K | — | Filing → |
| MAPP | SELL | 2010-07-02 | $182K | — | Filing → |
| MAPP | SELL | 2010-06-03 | $432K | — | Filing → |